The closing price of Emergent Biosolutions Inc (NYSE: EBS) was $2.41 for the day, down -2.43% from the previous closing price of $2.47. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 1219665 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of EBS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 0.71.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 02 ’23 when Zoon Kathryn C sold 1,830 shares for $8.35 per share. The transaction valued at 15,280 led to the insider holds 49,971 shares of the business.
Zoon Kathryn C sold 1,700 shares of EBS for $14,246 on May 25 ’23. The Director now owns 51,801 shares after completing the transaction at $8.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 125.81M and an Enterprise Value of 874.31M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.12 while its Price-to-Book (P/B) ratio in mrq is 0.19. Its current Enterprise Value per Revenue stands at 0.85 whereas that against EBITDA is -1.69.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $13.67, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 2.2298, while the 200-Day Moving Average is calculated to be 3.8454.
Shares Statistics:
EBS traded an average of 3.12M shares per day over the past three months and 1.81M shares per day over the past ten days. A total of 52.20M shares are outstanding, with a floating share count of 50.07M. Insiders hold about 4.08% of the company’s shares, while institutions hold 78.87% stake in the company. Shares short for EBS as of Feb 29, 2024 were 6.2M with a Short Ratio of 1.99, compared to 10.44M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.88% and a Short% of Float of 19.60%.
Earnings Estimates
The firm’s stock currently is rated by 1 analysts. On average, analysts expect EPS of -$0.83 for the current quarter, with a high estimate of -$0.83 and a low estimate of -$0.83, while EPS last year was -$3.17. The consensus estimate for the next quarter is -$0.63, with high estimates of -$0.63 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$2 and -$2 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is $3.67, with 1 analysts recommending between $3.67 and $3.67.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for EBS’s current fiscal year. The highest revenue estimate was $1.02B, while the lowest revenue estimate was $1.02B, resulting in an average revenue estimate of $1.02B. In the same quarter a year ago, actual revenue was $1.05B, down -2.30% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.13B in the next fiscal year. The high estimate is $1.13B and the low estimate is $1.13B. The average revenue growth estimate for next year is up 9.90% from the average revenue estimate for this year.
